murine typhus vaccine. In a group of 290 persons so inoculated, 218 (70 per cent) developed symptoms of murine typhus fever and one of these persons died from the disease.
With the growing realization of the dangers of the use of living vaccines, increasing efforts were directed toward the study of killed vaccines. The early work of da Rocha Lima"8 and of Weigl26 on the use of killed suspensions of infected lice or infected louse feces suggested that acquired immunity could be attained. However, these methods, along with the use of killed suspensions of organisms obtained from the peritoneal cavity of the rat29 or rodent lungs,3'8 were not practical for large-scale immunization.
Following the studies of Cox' which demonstrated that rickettsiae of the Rocky Mountain spotted fever and typhus groups could be grown in the yolk-sac membrane of the developing chick embryo, Cox and Bell5 prepared an epidemic typhus vaccine based upon the use of this tissue as a culture medium. This vaccine, consisting of a killed suspension of R. prowazeki grown in the yolk-sac membrane of the chick and purified by centrifugation, protected guinea-pigs against challenge with the virus. Subsequent modifications, such as Craigie's ether extraction' and the use of a so-called "soluble antigen"17' 25 lead to a vaccine that was satisfactory not only from the standpoint of potency but also from the aspect of commercial production. Indeed, production in biological houses in the United States during the World War II years reached as much as 75,000,000 cc. per year.
The epidemic typhus vaccine used by the U. S. Army consisted of a 10 per cent yolk-sac suspension of the Breinl strain of R. prowazeki, extracted with ether. This vaccine contains both rickettsial bodies and "soluble antigen."
Since early 1942 and throughout the war years all U. S. Army personnel going to, or stationed in, areas where epidemic typhus fever was present or suspected received this vaccine. Up through 1943, the initial vaccination consisted of three injections of typhus vaccine, 1.0 cc. each, administered subcutaneously at an interval of from 7 to 10 days, with stimulating or booster doses being given every 6 months in endemic areas. With increase in potency due to improvement in production, the initial immunization series was reduced in middle 1944 to 2 doses of vaccine and the stimulating dose was given at the beginning and in the middle of the typhus season (1 November and 1 February in the northern hemisphere).
Incidence and mortality of typhus fever following immunization Until processing of almost 20,000,000 individual medical records is completed in the Office of The Surgeon General, the most reliable data on the Army's morbidity from typhus are those obtained from the weekly summary known as the "Statistical Health Report" submitted by each Army hospital and separate dispensary. These data, while reasonably accurate, must be regarded as preliminary.
For the greater part of the war period, epidemic typhus, murine (endemic) typhus, and tsutsugamushi disease (scrub typhus) were included in the Statistical Health Report under the term "Typhus Fever," without differentiation between the various members of the typhus group. However, it is possible to obtain a fairly close approximation of morbidity from the specific diseases by grouping the cases under one of the three members of the typhus-like group according to geographic locality. For instance, it is evident that all cases of "typhus fever" contracted in and reported from the continental United States are murine typhus. Likewise, from epidemiological data and detailed studies of sampled case records, it is reasonable to suppose that cases of "typhus fever" reported from the Southwest Pacific and China-Burma-India areas are scrub typhus, although it is possible that a small number of these may actually be murine typhus or even epidemic typhus. On -4-. h C DDT to prevent lousiness) were routinely employed. Due to the difficulty of setting up an adequately controlled experiment in a human population on a sufficiently large scale, the question of whether or not vaccine will effectively reduce the incidence of epidemic typhus has not been conclusively demonstrated. However, certain recent studies indicate that typhus vaccine prepared from the yolk-sac membrane of the embryonated chicken egg will prevent or at least materially reduce the incidence of naturally acquired epidemic typhus. Both Stuart-Harris22 and Sachs 19 conclude that the results of their studies of typhus in the British Army suggest that reduction in incidence is effected by such immunization.
In order to support his conclusion, Stuart-Harris shows that while the total number of cases of typhus fever in the Middle East from January to September 1943 and in North Africa from January to April 1943 prior to general immunization was 232, this number fell to a total of 21 Clinical data pertaining to the above-mentioned 5 cases are summarized in Table 2 , and serological findings and typhus immunization records are presented in Table 3 .
Case 1. A 41-year-old male officer, member of the U.S.A. Typhus Com-mission, was engaged in typhus research work in Cairo, Egypt, with Case 2 for almost a month before the onset of the disease. Both were exposed daily to infection with typhus by examining patients, picking infected lice off rabbits and patients, and handling the grinding of infected louse feces for injection into experimental animals. During the preceding two years, this officer had received a total of 22 cc. of vaccine in single 1 cc. doses; 5 cc. of this vaccine was of an experimental lot and contained both epidemic and murine virus. his typhus research activities. On the 5th day, 26 May, he took to his bed because of headache, fatigue, and malaise. Backache was marked. The next day he reported to a medical dispensary where physical examination revealed a few pink papules on the left palm and wrist, a temperature of 99.2°F., and pulse of 100. The rash had disappeared by the following morning and except for a mild headache, anorexia, and sense of fatigue, the patient did well on bed rest in his quarters, reporting daily to the dispensary. He was afebrile by 28 May (7th day) and was permitted to remain out of bed on 31 May (10th day).
Prior to the onset of typhus, the Weil-Felix reaction was negative with both Proteus OX19 and OX2 antigens and the complement fixation titer was Although the Weil-Felix reaction was negative with both Proteus OX19 and Proteus OX2 antigens, the complement fixation titer with epidemic antigen was 1:8 three days before and 11 days after the last dose of vaccine.
On 23 June 1944, the patient awakened in the morning with a mild but troublesome frontal headache which persisted through most of the day. The following day the headache recurred together with malaise and easy fatigability. His temperature was 1010F. These symptoms persisted with an increase in both severity and extent of the headache so that he was admitted to the hospital late in the afternoon of the next day, 25 June. The following day his temperature was 100.4°F., pulse rate was 80, respiratory rate 20, blood pressure was 106/60. The onset of illness was on 2 April 1945 with headache, chilliness, marked fatigue, and mental depression. These symptoms persisted and on the following day he had a shaking chill. The next day, 3rd day of disease, he was admitted to the hospital for an elective surgical operation of minor nature. Although his temperature at this time was 100°F., physical examination revealed no abnormalities. He was closely observed and on the 4th and 5th days, although his temperature had risen to 103°with several shaking chills and with increase in headache, backache, and generalized malaise, no findings of a diagnostic nature other than cervical adenopathy and right upper quadrant pain were evident. During the next 6 days his temperature ranged from 101°F. to 104.5°F. and he complained bitterly of an excruciating headache. He was nauseated and vomited. Malaria, meningitis, hepatitis, and infectious mononucleosis were considered in the differential diagnosis with typhus fever, although no definite evidence could be obtained for any of these conditions. Finally, the diagnosis was clarified on the 8th day by the appearance of a crop of pink macules over the abdomen, chest, and back. This rash spread to the arms and to the legs by the following day, but began to fade shortly thereafter on the 10th day, with an abrupt fall in temperature on the 12th day. There were no hemorrhagic residua. The fever, which fell by crisis, reached normal by the afternoon of the 11th day. On the 11th day he was permitted to get out of bed, and convalescence was uneventful except for weakness and depression.
Many diagnostic procedures such as blood culture, lumbar puncture, blood smears, various agglutinations, etc., were performed on this patient in the early acute phase of the disease but were all essentially negative. X-ray of the chest on the 9th day revealed clear lung fields. The leukocyte count on the 11th day was 7,000 with 70 per cent polymorphonuclear neutrophils, 20 Illness began on 2 April 1945 with fever and headache. These symptoms became progressively more severe, together with anorexia during the ensuing 5 days. Finally, when the headache became excruciating, and a non-productive cough set in, he reported on the 8th day to a medical dispensary. His temperature was 103°F. He was not hospitalized but was put to bed in his quarters. The temperature progressively fell during the next several days, becoming normal by the 13th day, and the headache abated. He returned to work on the 14th day. There were no chills. Skin eruption was absent.
Appropriate laboratory procedures were not performed during the acute stage to confirm the diagnosis. A blood specimen collected on the 20th day and examined by the 1st Medical General Laboratory revealed a complement fixation with epidemic antigen of 1:128 and with murine antigen of 1:64. Unfortunately, no record exists of further specimens being examined for serology until 2 July 1945. This sample, examined at the Army Medical School in Washington, indicated that the complement fixation titer had dropped but was still positive in a titer of 1:40. Complement fixing antibodies were still present in titer of 1:20 almost a year after the onset of illness.
Clinical features of post-vaccination typhus
The clinical features of the 5 cases presented above are summarized in Table 2 . All of the individuals were male officers, three of them in their thirties and two in the fifth decade of life. With the exception of Case 4, all had received not only adequate amounts of vaccine but also stimulating doses within 11 to 73 days prior to the onset of disease. Case 4 had only an initial series of three 1 cc. doses of vaccine, the last dose having been administered almost a full year before the onset of typhus. In this connection it is interesting to note that he not only suffered the most severe attack of typhus of any of the group, with asthenia lasting well into late convalescence, but also presented a widespread eruption over the entire trunk, legs, and arms. The incubation period ranged from 10 to 13 days in the 3 cases in which it could be accurately determined, was questionable at 12 days in one case, and was less than 17 days in another. Only 2 of the 5 officers were sick enough Apr. 1945 Field, pulmonary inhalation 10 days Hospital Mod. severe 11 11 7000;8000 with an increase in the young neutrophilic fraction of the differential. There was no evidence in any of the cases of undue prostration, or of cardiovascular renal involvement.
The picture presented above is in decided contrast to the unvaccinated case of classical typhus. Here the temperature may remain elevated between 104 and 1060F. until the end of the second week, the patient becomes delirious, comatose, and finally stuporous, and signs of cardiovascular and renal involvement may appear. The rash is extensive and hemorrhagic, and convalescence is prolonged. Such an example is illus- Fig. 3 .
Of particular interest is the method of infection. In every instance there was considerable evidence to indicate that infection was not sustained by louse "bite" but rather by the inhalation or conjunctival absorption of suspended infected louse feces. It has been well known for many years that physicians and nurses attending cases of epidemic typhus fever contract the disease despite active and vigorous measures to prevent louse infestation.
The clinical features of the 5 cases of post-vaccination epidemic typhus described above are in general accord with those already described for laboratory12 23 and field7 10 infections. These studies show that the clinical course of epidemic typhus is greatly modified when infection occurs subsequent to immunization with vaccine. Fever is much lower and of shorter duration than in non-vaccinated cases, the period of hospitalization (if at all necessary) is markedly reduced, the extent and duration of rash are diminished, circulatory and nervous symptoms are lessened, and the incidence of complications is brought down to a very low figure. The most striking result of immunization, however, is the fact that there has not been a single death reported in the vaccinated series of any of these investigations. Indeed, we are not aware of a single authentic death from epidemic typhus fever when the disease was incurred subsequent to adequate immunization with etherextracted Cox type vaccine.
In many instances, the diagnosis of typhus is extraordinarily difficult in vaccinated individuals because of the remarkable modification of the clinical picture, and serologic procedures must be employed for confirmation. The only symptom which regularly remains is the severe headache.
Time limits for protection following immunization It is difficult at this time to state accurately the time limits within which one may expect satisfactory protection from typhus after vaccination. It would appear, however, that protection is adequate up to a year following vaccination and that there is little indication that vaccine exerts a favorable action unless it is given at least 1½V2 or 2 weeks prior to exposure.
Ecke and his colleagues10 observed, first, that there was no apparent diminution in benefit up to 325 days following a dose of typhus vaccine; and second, that while the course of illness was somewhat shorter and milder in a group who were vaccinated within 1½V2 to 2 weeks prior to the onset of the disease, fatality might occur. A 35-year-old male, who was vaccinated 3 days before the onset of disease, died with epidemic typhus. In the present report, Case 4 had not received vaccine for 11 months prior to the onset of disease. He ran a moderately severe course and had a fairly extensive rash. In the light of this experience it would appear reasonable to set a time limit for maximum effectiveness of vaccine not to exceed 6 months after the initial series or stimulating dose; and not to expect suitable protection unless the vaccine has been administered at least 4 weeks prior to the onset of disease or 2 weeks before exposure. In this connection, Topping, Henderson, and Bengston24 have shown the importance of the stimulating dose of vaccine in producing a high titer antibody that will persist for a considerable period of time.
Serological diagnosis Certain peculiarities in the serological picture of typhus infection following immunization and the diagnostic need for such tests warrant a brief discussion of the serological diagnosis.
The discovery of the Weil-Felix agglutination test, employing suspensions of certain strains of the proteus bacillus provided a serological reaction which was extensively used in the diagnosis of typhus fever. This reaction, while non-specific, was of great value. Subsequently it became known that not only did this reaction fail to differentiate between certain members of the group of rickettsial diseases, but also that it did not differentiate between epidemic and murine typhus. Such differentiation is of great importance in survey and control work with typhus fever. It also proved to be desirable in the case of troops who, during the past war, became infected with typhus.
The successful effort of Cox4 in cultivating rickettsiae in the yolk-sac of the fertile hen egg, and Craigie's6 demonstration of the ether method of extracting such cultures led to the preparation of an antigen with which appropriate serological studies could be performed. Bengston,1 using an antigen prepared in such manner, described a complement fixation test for murine typhus. This complement fixation reaction, as subsequently developed and elaborated, clearly differentiated typhus not only from other rickettsial diseases, but also served to separate epidemic from murine typhus, provided that certain precautions, as outlined by Plotz, Wertman, and Bennett,17 were closely followed. These investigators showed that when the rickettsial suspensions were rendered free of "'soluble antigen," specific complement fixing antigens were obtained with which these closely related diseases could be differentiated.
The serologic response in acquired epidemic typhus fever is now well defined and established. 15 The presence of agglutinins in rising titer for the proteus OX9 bacillus may be demonstrated between the fourth to thirteenth day, usually about the beginning of the second week. The titer rises during the second week to reach its maximum in early convalescence and usually disappears about 3 months after onset. Complement fixing and rickettsial agglutinating antibodies can be demonstrated during the second week of the disease. Rickettsial agglutination reaches a non-significant titer in late convalescence, while the complement fixing antibody seems to persist for years after an attack. Indeed, Plotz15 has found complement fixing antibodies in epidemic and murine typhus as long as 32 and 12 years, respectively, subsequent to the active infection.
Recently, the development of serologic response in man following the administration of epidemic typhus vaccine has been studied by Topping, Henderson, and Bengston24 and by Zarafonetis.27 These studies show that while such vaccination calls forth epidemic complement fixing antibodies in low titer, there is usually little or no response with the Weil-Felix test. While there is an increase in complement fixation titer as a result of "booster" or "stimulating" vaccination, the trend is still for a return to the pre-booster level within several months after the "booster" injection.
When an individual who has received typhus vaccine becomes infected with epidemic typhus, the Weil-Felix, rickettsial agglutination, and complement fixing antibodies appear somewhat earlier than in nonvaccinated individuals,15' 28 but continue to rise and eventually yield a serologic picture similar to that in the non-vaccinated case. In general, the titer obtained with complement fixing epidemic antigen exceeds that with murine antigen, but occasionally considerable cross-fixation may be observed.16 Until further data are obtained, it is unwise to depend solely upon the complement fixation reaction for differentiation between epidemic and murine typhus in those individuals who have been previously vaccinated.
In the case of the individual who contracts murine typhus subsequent to immunization with epidemic typhus vaccine, Plotz 
